Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 points of sale across 26 countries. With the announced acquisition of GN's hearing business, Amplifon is shifting its strategy from a pure-play retailer to a vertically integrated manufacturer, like its peers Demant and Sonova.
As Amplifon continues to build out its network, its bargaining power with suppliers will continue to improve leading to improved purchasing power and operating margins.
Amplifon’s aggressive M&A strategy will continue to require high capital investments, pressuring ROICs, and resulting in high personnel expenses.
|
Metric
|
AMP
|
DEMANT
|
GN
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.10 | 25.70 | 156.35 |
Price/Book Value | 2.07 | 5.89 | 1.54 |
Price/Sales | 1.14 | 2.69 | 1.23 |
Price/Cash Flow | 6.69 | 15.51 | 6.88 |
|
Metric
|
AMP
|
DEMANT
|
GN
|
|---|---|---|---|
Quick Ratio | 0.67 | 0.54 | 0.38 |
Current Ratio | 0.73 | 0.82 | 1.93 |
Interest Coverage | 2.74 | 6.70 | 0.18 |
|
Metric
|
AMP
|
DEMANT
|
GN
|
|---|---|---|---|
Return on Assets (Normalized) | 4.29% | 6.76% | −0.53% |
Return on Equity (Normalized) | 15.29% | 24.80% | −1.48% |
Return on Invested Capital (Normalized) | 7.08% | 9.75% | 0.50% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|?y$SK> | LOCK|rg#kf | $105B | |||
| Cencora Inc
COR
| LOCK|##bs@rJ | LOCK|H<FFx | $59B | |||
| Cardinal Health Inc
CAH
| LOCK|Gckffq< | LOCK|J&@Z | $53B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|%tlWq | $21B | |||
| Henry Schein Inc
HSIC
| LOCK|jBd??t& | LOCK|<h%$ | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|knl | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|^?$ | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|t% | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|d^gMz | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|%P^ | $4B |
United States